Yuvraj_pawp, Author at Pharma Advancement

US-based Arena Pharmaceuticals has started dosing patients in an investigational Phase Ib clinical trial of APD334, an oral drug candidate...

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream in 2014

by Yuvraj_pawp

5th June 2014

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs...

Point of Care Set to Boom in Coming Years; Driving Forward Quality and Maximising Efficiency

by Yuvraj_pawp

5th June 2014

The global market for Point of Care diagnostics is set to sharply increase by 2018 and Europe’s market is becoming...

Chemistry: Provence Technologies acquires Synprosis

by Yuvraj_pawp

2nd June 2014

Provence Technologies acquires SynprosisThe acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic chemistry Provence Technologies Group, a...

AstraZeneca’s Bydureon achieves better glycaemic control than insulin glargine in type 2 diabetes

by Yuvraj_pawp

2nd June 2014

UK-based AstraZeneca has reported results from its longest, randomised, head-to-head DURATION-3 trial of exenatide once-weekly, a long-acting glucagon-like peptide-1 (GLP-1)...

Boston Therapeutics begins Phase IIb Sugardown trial for type 2 diabetes patients

by Yuvraj_pawp

2nd June 2014

US-based Boston Therapeutics (BTI) has started a Phase IIb clinical trial SD-002 to evaluate the efficacy and safety of Sugardown...

KIP THE HUMANS: DRUG DISCOVERY BY SIMULATING CELLS

by Yuvraj_pawp

2nd June 2014

The future of medicine, we're often told, will be personalized. We'll have gene therapies, wearables to monitor our vital signs—maybe...

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream in 2014

by Yuvraj_pawp

29th May 2014

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as...

VA’S CONVOLUTED PATIENT SCHEDULING STARTS WITH A ‘HELPLINE’ CALL

by Yuvraj_pawp

28th May 2014

Veterans trying to schedule medical appointments in the Veterans Affairs Department’s Phoenix Health Care System entered a Kafkaesque world where...

Polyplus-transfection launches a new transfection reagent for bioproduction

by Yuvraj_pawp

28th May 2014

Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO(TM),...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Yuvraj_pawp

Arena begins Phase Ib trial of APD334 to treat autoimmune diseases

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream in 2014

Point of Care Set to Boom in Coming Years; Driving Forward Quality and Maximising Efficiency

Chemistry: Provence Technologies acquires Synprosis

AstraZeneca’s Bydureon achieves better glycaemic control than insulin glargine in type 2 diabetes

Boston Therapeutics begins Phase IIb Sugardown trial for type 2 diabetes patients

KIP THE HUMANS: DRUG DISCOVERY BY SIMULATING CELLS

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream in 2014

VA’S CONVOLUTED PATIENT SCHEDULING STARTS WITH A ‘HELPLINE’ CALL

Polyplus-transfection launches a new transfection reagent for bioproduction

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password